M
Masato Ogishi
Researcher at Rockefeller University
Publications - 32
Citations - 2609
Masato Ogishi is an academic researcher from Rockefeller University. The author has contributed to research in topics: Medicine & Biology. The author has an hindex of 9, co-authored 20 publications receiving 1178 citations. Previous affiliations of Masato Ogishi include University of Tokyo.
Papers
More filters
Journal ArticleDOI
Human T-bet governs the generation of a distinct subset of CD11chighCD21low B cells
Rui-Fu Yang,Danielle T. Avery,Katherine J. L. Jackson,Masato Ogishi,Ibtihal Benhsaien,Likun Du,Xiaofei Ye,Jing Han,Jérémie Rosain,Jessica N. Peel,Marie-Alexandra Alyanakian,Bénédicte Neven,Sarah Winter,Anne Puel,Bertrand Boisson,Kathryn Payne,Melanie Wong,Amanda J. Russell,Yoko Mizoguchi,Satoshi Okada,Gulbu Uzel,Christopher C. Goodnow,Sylvain Latour,Jalila El Bakkouri,Aziz Bousfiha,Kahn Preece,Paul Gray,Baerbel Keller,Klaus Warnatz,Stéphanie Boisson-Dupuis,Laurent Abel,Qiang Pan-Hammarström,Jacinta Bustamante,Cindy S. Ma,Jean-Laurent Casanova,Stuart G. Tangye +35 more
TL;DR: A patient with inherited T-bet deficiency and largely normal humoral immunity including intact somatic hypermutation, affinity maturation and memory B cell formation in vivo, and B cell differentiation into Ig-producing plasmablasts in vitro is described.
Journal ArticleDOI
Multibatch Cytometry Data Integration for Optimal Immunophenotyping.
Masato Ogishi,Rui Yang,Conor Gruber,Peng Zhang,Simon J. Pelham,András N Spaan,Jérémie Rosain,Jérémie Rosain,Marwa Chbihi,Ji Eun Han,V. Koneti Rao,Leena Kainulainen,Jacinta Bustamante,Bertrand Boisson,Bertrand Boisson,Bertrand Boisson,Dusan Bogunovic,Stéphanie Boisson-Dupuis,Stéphanie Boisson-Dupuis,Stéphanie Boisson-Dupuis,Jean-Laurent Casanova +20 more
TL;DR: The integration of multibatch cytometry datasets (iMUBAC), a flexible, scalable, and robust computational framework for unsupervised cell-type identification across multiple batches of high-dimensional cytometry dataset, even without technical replicates is described.
Journal ArticleDOI
Deconvoluting the composition of low-frequency hepatitis C viral quasispecies: comparison of genotypes and NS3 resistance-associated variants between HCV/HIV coinfected hemophiliacs and HCV monoinfected patients in Japan.
Masato Ogishi,Hiroshi Yotsuyanagi,Takeya Tsutsumi,Hiroyuki Gatanaga,Hirotaka Ode,Wataru Sugiura,Kyoji Moriya,Shinichi Oka,Satoshi Kimura,Kazuhiko Koike +9 more
TL;DR: A methodological framework based on Illumina MiSeq next-generation sequencing (NGS) coupled with bioinformatics of quasispecies reconstruction (QSR) to realize highly accurate variant calling and genotype-haplotype detection of pre-existing minor Gts, RAVs, and their interrelationships is characterized.
Journal ArticleDOI
Inherited human c-Rel deficiency disrupts myeloid and lymphoid immunity to multiple infectious agents
Romain Lévy,David Langlais,Vivien Béziat,Vivien Béziat,Franck Rapaport,Geetha Rao,Tomi Lazarov,Mathieu Bourgey,Yu Jerry Zhou,Coralie Briand,Kunihiko Moriya,Fatima Ailal,Danielle T. Avery,Janet Markle,Ai Ing Lim,Masato Ogishi,Rui Yang,Simon J. Pelham,Mehdi Emam,Mélanie Migaud,Caroline Deswarte,Tanwir Habib,Luis R. Saraiva,Eman Abou Moussa,Andrea Guennoun,Bertrand Boisson,Bertrand Boisson,Serkan Belkaya,Rubén Martínez-Barricarte,Jérémie Rosain,Aziz Belkadi,Sylvain Breton,Kathryn Payne,Ibtihal Benhsaien,Alessandro Plebani,Vassilios Lougaris,James P. Di Santo,Bénédicte Neven,Laurent Abel,Laurent Abel,Cindy S. Ma,Ahmed Aziz Bousfiha,Nico Marr,Jacinta Bustamante,Jacinta Bustamante,Kang Liu,Philippe Gros,Frederic Geissmann,Stuart G. Tangye,Jean-Laurent Casanova,Anne Puel,Anne Puel +51 more
TL;DR: In this paper, a child with severe viral, bacterial, fungal, and parasitic diseases was homozygous for a loss-of-function mutation of REL, encoding c-Rel, which is selectively expressed in lymphoid and myeloid cells.
Journal ArticleDOI
Delineation of autoantibody repertoire through differential proteogenomics in hepatitis C virus-induced cryoglobulinemia
TL;DR: This study provides a proof-of-concept of de novo mining of autoantibodies and corresponding autoantigen candidates in a disease-specific context in human, thus facilitating future reverse-translational research for the discovery of novel biomarkers and the development of antigen-specific immunotherapy against variousAutoantibody-related disorders.